Extract from a press-conference held in San Francisco, Sept 1990. Dr P Cheney. CFIDS Chronicle, Sept 1990:7-8


Testing of Vestibular Function: An Adjunct in the Assessment of Chronic Syndrome. JMR Furman. Reviews of Infectious Diseases 1991:13 (Suppl 1):S109­11


A Comparative Review of Systemic and Neurological Symptomatology in 12 Outbreaks Collectively Described as Chronic Fatigue Syndrome, Epidemic Neuromyasthenia, and Myalgic Encephalomyelitis. NC Briggs, PH Levine. Clinical Infectious Diseases 1994:18 (Suppl 1):S32-42

Chronic Fatigue Syndrome Update - Findings Now Point To Central Nervous System Involvement. DS Bell. Postgraduate Medicine 1994:96:6:73-81


Vestibular Function Test Anomalies in Patients with Chronic Fatigue Syndrome. R Ash­Bernal, C Wall et al. Acta Otolaryngol (Stockh) 1995:115:9-17


Decreased vagal power during treadmill walking in patients with chronic fatigue syndrome. DL Cordero, WN Tapp et al. Clinical Autonomic Research 1996:6:329-333

Medical Matters: Problems with Balance. UK ME Association Newsletter (Perspectives) September 1996:iv


Does the Chronic Fatigue Syndrome Involve the Autonomic Nervous System? R Freeman, MD Anthony, L Komaroff. The American Journal of Medicine 1997:102:357­364


Neurally Mediated Hypotension and Chronic Fatigue Syndrome. PC Rowe, H Calkins. The American Journal of Medicine 1998:105(3A):15S-21S


Chronic Fatigue Syndrome is an Acquired Neurological Channelopathy. A Chaudhuri, PO Behan. Hum. Psychopharmacol. Clin. Exp. 1999:14:7-17


Pall ML. 2000b. Elevated peroxynitrite as the cause of chronic fatigue syndrome: Other inducers and mechanisms of symptom generation. J Chronic Fatigue Syndrome 7(4):45-58.

Pall ML. 2001b. Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite. Medical Hypoth 57:139-145.

Pall ML. 2002b. NMDA sensitization and stimulation by peroxynitrite, nitric oxide, and organic solvents as the mechanism of chemical sensitivity in multiple chemical sensitivity. FASEB J 16:1407-1417.